Unknown

Dataset Information

0

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis.


ABSTRACT: Tumor-associated macrophages (TAMs) that appear in every stage of cancer progression are usually tumor-promoting cells and are present abundantly in the tumor-associated microenvironment. In ovarian cancer, the overall and intratumoral M1/M2 ratio is a relatively efficient TAM parameter for predicting the prognosis of patients, especially for serous tissue type cancer. TAMs exhibit immunological checkpoint modulators, such as the B7 family and programmed death-ligand 1 (PD-L1), and play a key role in the development, metastasis and invasion of ovarian cancer, but the underlying mechanism is barely understood. Ovarian cancer is a severe gynecological malignancy with high mortality. Ovarian cancer-associated death can primarily be attributed to cancer metastasis. The majority of patients are diagnosed with wide dissemination in the peritoneum and omentum, limiting the effectiveness of surgery and chemotherapy. In addition, unlike other well-documented cancers, metastasis through vasculature is not a usual dissemination pathway in ovarian cancer. This review sheds light on TAMs and the main process and mechanism of ovarian cancer metastasis.

SUBMITTER: Yin M 

PROVIDER: S-EPMC6814357 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis.

Yin Meichen M   Shen Jiayu J   Yu Shuqian S   Fei Jing J   Zhu Xiaoqing X   Zhao Jiayao J   Zhai Lingyun L   Sadhukhan Annapurna A   Zhou Jianwei J  

OncoTargets and therapy 20191021


Tumor-associated macrophages (TAMs) that appear in every stage of cancer progression are usually tumor-promoting cells and are present abundantly in the tumor-associated microenvironment. In ovarian cancer, the overall and intratumoral M1/M2 ratio is a relatively efficient TAM parameter for predicting the prognosis of patients, especially for serous tissue type cancer. TAMs exhibit immunological checkpoint modulators, such as the B7 family and programmed death-ligand 1 (PD-L1), and play a key ro  ...[more]

Similar Datasets

| S-EPMC6160505 | biostudies-literature
| S-EPMC5096908 | biostudies-other
| S-EPMC5686549 | biostudies-literature
| S-EPMC8578434 | biostudies-literature
| S-EPMC6780667 | biostudies-literature
| S-EPMC7670061 | biostudies-literature
| S-EPMC7714989 | biostudies-literature
| S-EPMC7722725 | biostudies-literature
| S-EPMC3141071 | biostudies-literature
| S-EPMC7186717 | biostudies-literature